CN112779211A - 一种优化的人脂肪间充质干细胞培养体系 - Google Patents
一种优化的人脂肪间充质干细胞培养体系 Download PDFInfo
- Publication number
- CN112779211A CN112779211A CN201911097527.XA CN201911097527A CN112779211A CN 112779211 A CN112779211 A CN 112779211A CN 201911097527 A CN201911097527 A CN 201911097527A CN 112779211 A CN112779211 A CN 112779211A
- Authority
- CN
- China
- Prior art keywords
- cells
- cell
- culture
- adipose
- stem cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000002901 mesenchymal stem cell Anatomy 0.000 title claims abstract description 19
- 238000004113 cell culture Methods 0.000 title claims abstract description 12
- 210000004027 cell Anatomy 0.000 claims abstract description 79
- 210000000130 stem cell Anatomy 0.000 claims abstract description 39
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims abstract description 30
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims abstract description 30
- 229960004488 linolenic acid Drugs 0.000 claims abstract description 30
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 claims abstract description 30
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims abstract description 29
- 239000005642 Oleic acid Substances 0.000 claims abstract description 28
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims abstract description 24
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims abstract description 24
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims abstract description 24
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims abstract description 24
- 239000001963 growth medium Substances 0.000 claims abstract description 24
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims abstract description 24
- 238000012258 culturing Methods 0.000 claims abstract description 22
- 230000035755 proliferation Effects 0.000 claims abstract description 20
- 238000000034 method Methods 0.000 claims abstract description 12
- 238000005406 washing Methods 0.000 claims abstract description 9
- 108010019160 Pancreatin Proteins 0.000 claims abstract description 7
- 210000000577 adipose tissue Anatomy 0.000 claims abstract description 7
- 229940055695 pancreatin Drugs 0.000 claims abstract description 7
- 230000007910 cell fusion Effects 0.000 claims abstract description 5
- 102000029816 Collagenase Human genes 0.000 claims abstract description 4
- 108060005980 Collagenase Proteins 0.000 claims abstract description 4
- 229960002424 collagenase Drugs 0.000 claims abstract description 4
- 238000001914 filtration Methods 0.000 claims abstract description 4
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 18
- 229930195729 fatty acid Natural products 0.000 claims description 18
- 239000000194 fatty acid Substances 0.000 claims description 18
- 239000002609 medium Substances 0.000 claims description 18
- 150000004665 fatty acids Chemical class 0.000 claims description 17
- 239000000243 solution Substances 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 11
- 230000029087 digestion Effects 0.000 claims description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 5
- 206010033675 panniculitis Diseases 0.000 claims description 5
- 210000004003 subcutaneous fat Anatomy 0.000 claims description 5
- 239000012091 fetal bovine serum Substances 0.000 claims description 4
- 230000001965 increasing effect Effects 0.000 claims description 4
- 239000002504 physiological saline solution Substances 0.000 claims description 4
- 210000004369 blood Anatomy 0.000 claims description 3
- 239000008280 blood Substances 0.000 claims description 3
- 235000019197 fats Nutrition 0.000 claims description 3
- 230000001939 inductive effect Effects 0.000 claims description 3
- 239000008188 pellet Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 2
- 230000001079 digestive effect Effects 0.000 claims description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 239000006166 lysate Substances 0.000 claims description 2
- 230000001464 adherent effect Effects 0.000 claims 1
- 238000002955 isolation Methods 0.000 claims 1
- 230000009815 adipogenic differentiation Effects 0.000 abstract description 9
- 230000004083 survival effect Effects 0.000 abstract description 9
- 101710160107 Outer membrane protein A Proteins 0.000 abstract description 3
- 239000000654 additive Substances 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 230000004663 cell proliferation Effects 0.000 abstract description 2
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 239000002244 precipitate Substances 0.000 abstract 1
- 239000006228 supernatant Substances 0.000 abstract 1
- 239000006285 cell suspension Substances 0.000 description 8
- 239000002253 acid Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000002293 adipogenic effect Effects 0.000 description 4
- 230000004069 differentiation Effects 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 4
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 4
- 102100022464 5'-nucleotidase Human genes 0.000 description 3
- 102100032912 CD44 antigen Human genes 0.000 description 3
- 101000678236 Homo sapiens 5'-nucleotidase Proteins 0.000 description 3
- 101000868273 Homo sapiens CD44 antigen Proteins 0.000 description 3
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 3
- 101000800116 Homo sapiens Thy-1 membrane glycoprotein Proteins 0.000 description 3
- NPGIHFRTRXVWOY-UHFFFAOYSA-N Oil red O Chemical compound Cc1ccc(C)c(c1)N=Nc1cc(C)c(cc1C)N=Nc1c(O)ccc2ccccc12 NPGIHFRTRXVWOY-UHFFFAOYSA-N 0.000 description 3
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 3
- 102100033523 Thy-1 membrane glycoprotein Human genes 0.000 description 3
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000007619 statistical method Methods 0.000 description 3
- OZFAFGSSMRRTDW-UHFFFAOYSA-N (2,4-dichlorophenyl) benzenesulfonate Chemical compound ClC1=CC(Cl)=CC=C1OS(=O)(=O)C1=CC=CC=C1 OZFAFGSSMRRTDW-UHFFFAOYSA-N 0.000 description 2
- 102100022749 Aminopeptidase N Human genes 0.000 description 2
- 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 2
- 102100037241 Endoglin Human genes 0.000 description 2
- 101000757160 Homo sapiens Aminopeptidase N Proteins 0.000 description 2
- 101000881679 Homo sapiens Endoglin Proteins 0.000 description 2
- 101000935043 Homo sapiens Integrin beta-1 Proteins 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 102100025304 Integrin beta-1 Human genes 0.000 description 2
- 102100024616 Platelet endothelial cell adhesion molecule Human genes 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 238000007664 blowing Methods 0.000 description 2
- 238000012136 culture method Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000000684 flow cytometry Methods 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 150000004671 saturated fatty acids Chemical class 0.000 description 2
- 235000003441 saturated fatty acids Nutrition 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- APIXJSLKIYYUKG-UHFFFAOYSA-N 3 Isobutyl 1 methylxanthine Chemical compound O=C1N(C)C(=O)N(CC(C)C)C2=C1N=CN2 APIXJSLKIYYUKG-UHFFFAOYSA-N 0.000 description 1
- 206010006242 Breast enlargement Diseases 0.000 description 1
- -1 CD31 Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 1
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 1
- 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 description 1
- 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 230000011759 adipose tissue development Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000002659 cell therapy Methods 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000001612 chondrocyte Anatomy 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000012007 large scale cell culture Methods 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 125000005481 linolenic acid group Chemical group 0.000 description 1
- 238000007443 liposuction Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000004409 osteocyte Anatomy 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000003625 skull Anatomy 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000005740 tumor formation Effects 0.000 description 1
- 239000012224 working solution Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/36—Lipids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/80—Undefined extracts from animals
- C12N2500/84—Undefined extracts from animals from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Developmental Biology & Embryology (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Rheumatology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911097527.XA CN112779211A (zh) | 2019-11-04 | 2019-11-04 | 一种优化的人脂肪间充质干细胞培养体系 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911097527.XA CN112779211A (zh) | 2019-11-04 | 2019-11-04 | 一种优化的人脂肪间充质干细胞培养体系 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112779211A true CN112779211A (zh) | 2021-05-11 |
Family
ID=75749844
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911097527.XA Pending CN112779211A (zh) | 2019-11-04 | 2019-11-04 | 一种优化的人脂肪间充质干细胞培养体系 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112779211A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115025122A (zh) * | 2022-06-25 | 2022-09-09 | 广东旺合生物科技有限公司 | 自体脂肪干细胞在制备抗衰老和抗免疫低下的药物或制品中的应用 |
CN115521908A (zh) * | 2022-10-24 | 2022-12-27 | 潍坊天创生物科技有限公司 | 一种脂肪间充质干细胞的体外培养及外泌体的分离纯化方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103243070A (zh) * | 2013-04-25 | 2013-08-14 | 刘小青 | 一种干细胞培养基及其应用 |
CN109022358A (zh) * | 2018-10-05 | 2018-12-18 | 淮安康宜莱干细胞生物科技有限公司 | 促进人脂肪干细胞增殖的方法 |
-
2019
- 2019-11-04 CN CN201911097527.XA patent/CN112779211A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103243070A (zh) * | 2013-04-25 | 2013-08-14 | 刘小青 | 一种干细胞培养基及其应用 |
CN109022358A (zh) * | 2018-10-05 | 2018-12-18 | 淮安康宜莱干细胞生物科技有限公司 | 促进人脂肪干细胞增殖的方法 |
Non-Patent Citations (4)
Title |
---|
张靖伟;姚英俊;梁媛;王晗;王际辉;: "油酸对C57/BL6J小鼠脂肪干细胞体外成脂分化的影响" * |
张靖伟等: "油酸对C57/BL6J小鼠脂肪干细胞体外成脂分化的影响", 《大连工业大学学报》 * |
曾瑞霞: "p62通过自噬调节油酸诱导人脂肪间充质干细胞成脂的作用", 《中国博士论文电子期刊》 * |
梁媛等: "亚油酸和α-亚麻酸对脂肪干细胞活力及成脂分化的影响", 《大连工业大学学报》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115025122A (zh) * | 2022-06-25 | 2022-09-09 | 广东旺合生物科技有限公司 | 自体脂肪干细胞在制备抗衰老和抗免疫低下的药物或制品中的应用 |
CN115521908A (zh) * | 2022-10-24 | 2022-12-27 | 潍坊天创生物科技有限公司 | 一种脂肪间充质干细胞的体外培养及外泌体的分离纯化方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108359636B (zh) | 一种提高多能干细胞定向分化为心肌细胞的诱导方法 | |
CN104164403B (zh) | 一种提取及培养脂肪干细胞的方法 | |
WO2016049986A1 (zh) | 一种脐带间充质干细胞的分离方法 | |
CN108300690A (zh) | 一种脂肪间充质干细胞的分离培养方法和无血清培养基 | |
CN105602896A (zh) | 一种猪脂肪干细胞分离培养及鉴定的方法 | |
CN105039248B (zh) | 树鼩骨髓间充质干细胞培养系统 | |
CN112779211A (zh) | 一种优化的人脂肪间充质干细胞培养体系 | |
WO2023016029A1 (zh) | 一种分离来源于人类诱导多能干细胞的成纤维细胞的方法及其应用 | |
CN109628388B (zh) | 用消化酶组合物从胎盘血管分离间充质干细胞 | |
CN110846273A (zh) | 一种脂肪组织来源的间充质干细胞培养及三系分化诱导方法 | |
CN104726401A (zh) | 一种利用胎盘间充质干细胞提高脐血间充质干细胞培养成功率的方法 | |
CN108753709A (zh) | 一种无血清培养基及其制备与细胞培养方法 | |
CN107236705B (zh) | 一种人胎盘绒毛膜间充质干细胞培养体系 | |
CN108410796B (zh) | 一种诱导人间充质干细胞向血管内皮细胞分化的方法 | |
CN110499279B (zh) | 一种诱导人尿源性干细胞向肝细胞分化的方法 | |
CN105886462A (zh) | 用于ADSCs培养的组合物及ADSCs培养方法 | |
CN1330142A (zh) | 人骨髓和脐带血间充质干细胞体外分离扩增和向神经细胞定向诱导的方法 | |
CN111172104A (zh) | 一种脐血间充质干细胞的分离培养方法 | |
CN114790443B (zh) | 一种间充质干细胞体外培养方法及其培养基 | |
CN112941017A (zh) | 一种诱导人间充质干细胞成脂分化培养基及其制备方法 | |
CN108034634B (zh) | 一种从经血中分离宫内膜间充质干细胞的方法 | |
CN102796701A (zh) | 体外3d无支架悬浮培养扩增人脐带间充质干细胞的方法 | |
CN106867965B (zh) | 一种脂肪干细胞高效诱导分化剂和诱导分化培养基 | |
CN113201491B (zh) | 一种促进干细胞体外增殖和分化的培养方法 | |
CN115029305A (zh) | 猪FAPs细胞分离鉴定方法及FAPs细胞的用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20210810 Address after: Room 407, building 3, No. 430, Nancheng section, Dongguan Avenue, Nancheng street, Dongguan City, Guangdong Province, 523000 Applicant after: Dongguan Xuanguan stem cell regenerative medicine Co.,Ltd. Address before: 523000 Huihai Building Shop 409-411, 430 Dongguan Avenue, Yuanwubian Community, Nancheng Street, Dongguan City, Guangdong Province Applicant before: Dongguan Enlian Stem Cell Biotechnology Research Institute |
|
TA01 | Transfer of patent application right | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20210511 |
|
WD01 | Invention patent application deemed withdrawn after publication |